Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review

被引：0
|
作者：
Melanie Plested
Sangeeta Budhia
Zahava Gabriel
机构：
[1] Butterfield Technology Park,Heron Evidence Development Ltd
[2] Pfizer Ltd,undefined
[3] Walton Oaks,undefined
来源：
BMC Neurology | / 10卷
关键词：
Lower Back Pain; Neuropathic Pain; Gabapentin; Pregabalin; Duloxetine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster
    Wilhelm, Ilca Ricarda
    Tzabazis, Alexander
    Likar, Rudolf
    Sittl, Reinhard
    Griessinger, Norbert
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2010, 27 (02) : 169 - 173
  • [22] Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain
    Boyle, Julia
    Eriksson, Malin E. V.
    Gribble, Laura
    Gouni, Ravi
    Johnsen, Sigurd
    Coppini, David V.
    Kerr, David
    DIABETES CARE, 2012, 35 (12) : 2451 - 2458
  • [23] THE EFFECT OF MEDICATION CHOICE BETWEEN DULOXETINE AND PREGABALIN ON MEDICATION COMPLIANCE AMONG PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN
    Sun, P.
    Zhao, Y.
    Bledsoe, S.
    Watson, P. R.
    VALUE IN HEALTH, 2009, 12 (03) : A103 - A103
  • [24] Intravenous Lidocaine for Chronic Neuropathic Pain A Systematic Review Addressing Nursing Care
    Lancaster, Rachelle J.
    Wren, Kathleen
    Hudson, Amy
    Leavitt, Karen
    Albala, Maurizio
    Tischaefer, Dawn
    PAIN MANAGEMENT NURSING, 2020, 21 (02) : 194 - 200
  • [25] Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?
    Kern, Kai-Uwe
    Nalamachu, Srinivas
    Brasseur, Louis
    Zakrzewska, Joanna M.
    JOURNAL OF PAIN RESEARCH, 2013, 6 : 261 - 279
  • [26] Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin
    Zhao, Yang
    Watson, Peter
    Sun, Peter
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (04) : 785 - 792
  • [27] Comparative Benefit-Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach
    Sabatschus, Ingo
    Boesl, Irmgard
    Prevoo, Marlou
    Eerdekens, Marieelle
    Spruenken, Arne
    Galm, Oliver
    Forstner, Michael
    PAIN AND THERAPY, 2022, 11 (01) : 73 - 91
  • [28] Review of duloxetine in the management of diabetic peripheral neuropathic pain
    Smith, Timothy
    Nicholson, Robert A.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (06) : 833 - 844
  • [29] Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison
    Tanenberg, Robert J.
    Irving, Gordon A.
    Risser, Richard C.
    Ahl, Jonna
    Robinson, Michael J.
    Skliarevski, Vladimir
    Malcolm, Sandra K.
    MAYO CLINIC PROCEEDINGS, 2011, 86 (07) : 615 - 624
  • [30] Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine
    Freynhagen, R.
    Grond, S.
    Schuepfer, G.
    Hagebeuker, A.
    Schmelz, M.
    Ziegler, D.
    Von Giesen, H. -J.
    Junker, U.
    Wagner, K. J.
    Konrad, C.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (12) : 1989 - 1996
12345